Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Anticipated Earnings Report and Guidance for Cabot

Elaine Mendonca by Elaine Mendonca
February 2, 2024
in Breaking News
0
Finance_Banking (2)
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On February 2, 2024, Cabot (NYSE:CBT) is set to unveil its latest quarterly earnings report, which is highly anticipated by investors. The company’s performance in the previous quarter exceeded expectations, resulting in a significant boost to its share price. Analysts predict that Cabot will report an earnings per share (EPS) of $1.49 for the quarter ending in December 2023.

The market has observed that Cabot’s stock price is greatly influenced by its earnings and guidance. While an earnings beat or miss is not the sole determinant of stock price movement, the provided guidance and forecasted growth for the next quarter also play a crucial role. It is essential for investors to closely monitor the company’s earnings release and the subsequent guidance or forecast, as these factors are likely to have a substantial impact on the stock price.

As of January 31, 2024, Cabot’s shares were trading at $73.18, reflecting a 2.03% decrease over the past 52 weeks. This indicates the need for careful observation and analysis of the upcoming earnings report and guidance, as it may have implications for the stock’s performance.

For more detailed information, interested individuals can visit the earnings calendar on Benzinga’s website. Cabot is scheduled to report its earnings on February 5, 2024, after the market closes. Analysts are expecting the company to announce earnings of $1.49 per share for the quarter. Furthermore, Cabot has set its FY24 guidance at $6.30-6.80 EPS. Notably, in the previous quarter, Cabot surpassed analyst estimates by reporting quarterly earnings of $1.65 per share.

CBT Stock Price Drops on February 2, 2024: Analysis and Concerns for Investors

On February 2, 2024, CBT stock had a drop in price. According to data from CNN Money, the stock opened at $71.94, which was $1.24 lower than its previous close.

However, despite these indicators, CBT experienced a price decrease on February 2. The stock’s price dropped by $1.18, which represented a 1.61% decrease from the previous market close. This decline may have been disappointing for investors who were hoping for a positive price movement.

Overall, CBT stock’s performance on February 2, 2024, was marked by a decrease in price. While the stock was trading in the middle of its 52-week range and near its 200-day simple moving average, the drop in price may have been a cause for concern for investors. As with any investment, it is essential to carefully consider all available information and consult with a financial advisor before making any investment decisions.

CBT Stock Performance on February 2, 2024: Promising Growth in Net Income and EPS

CBT Stock Performance on February 2, 2024:

CBT’s total revenue for the past year stood at $3.93 billion, reflecting a 9.03% decrease compared to the previous year. However, the company managed to hold its total revenue flat since the last quarter, with reported revenues of $965.00 million.

Moving on to net income, CBT exhibited remarkable growth over the past year. With a net income of $437.00 million, the company witnessed a substantial 112.14% increase compared to the previous year. Additionally, the net income surged by an impressive 180.49% since the last quarter, reaching $230.00 million.

Furthermore, CBT’s earnings per share (EPS) also experienced substantial growth. The EPS for the past year was reported at $7.73, marking a remarkable 113.64% increase compared to the previous year. Similarly, the EPS surged by an astounding 185.98% since the last quarter, reaching $4.10.

CBT’s stock performance on February 2, 2024, appears promising, with notable increases in net income and EPS. While the total revenue experienced a slight decline over the past year, it remained stable since the last quarter.

Investors and stakeholders should closely monitor CBT’s future performance to assess its sustainability and growth potential. While the past year has seen remarkable growth in net income and EPS, it is crucial to analyze whether these positive trends will continue in the coming quarters. External factors such as market conditions, industry competition, and global economic trends may influence CBT’s future performance.

In conclusion, CBT’s stock performance on February 2, 2024, highlighted significant growth in net income and EPS, despite a slight decline in total revenue over the past year. These figures indicate the company’s ability to generate higher profits and improve its profitability per outstanding share. However, it is essential for investors to remain vigilant and monitor CBT’s future performance to assess its long-term sustainability and growth potential.

Tags: CBT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Anticipation Builds for Cheggs Quarterly Earnings Report

Finance_ Chart up

UnitedGuardian Inc Announces Impressive Dividend Increase and Commitment to Shareholder Value

Anticipating Air Products Chemicals Quarterly Earnings Report

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com